1. Expedia Receives Consensus Hold Rating from Analysts $EXPE http://www.analystratings.net/stocks/NASDAQ/EXPE/

  2. $EXPE still looks attractive (rated 6.3 as price is up to 94.80). Price vs ratings chart: https://www.v2ratings.com/ratings/t/expe

  3. $PCLN $EXPE $OWW 4Q14 vs. 4Q13 gross bookings. Priceline $10.7Bil. Expedia $10.65Bil; Orbitz Worldwide $2.7Bil.

  4. $PCLN vs. $EXPE vs. $NFLX vs. $BABA Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=PCLN|EXPE|NFLX|BABA|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  5. $EXPE Quality past performance however with suspect future prospects. Infographic: http://simplywall.st/NasdaqGS:EXPE/expedia

  6. $NFLX vs. $AMZN vs. $EXPE vs. $BABA Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=NFLX|AMZN|EXPE|BABA|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  7. $PCLN vs. $NFLX vs. $JD vs. $EXPE Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=PCLN|NFLX|JD|EXPE|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  8. $EXPE in 3-Drives pattern

  9. NASDAQ DROPS IN SHORTS: $OREX $AAPL $ARIA $CLDX $ARUN $PCYC $AMAT $GPRO $AMAT $GRPN $ALTR $TRIP $STLD $Z $EXPE

  10. $PCLN vs. $BABA vs. $JD vs. $EXPE Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=PCLN|BABA|JD|EXPE|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  11. Libardo Lambrano holds an allocation of 11.9% in $EXPE in his Dividend Paying Large Caps Investment Portfolio

  12. $PCLN vs. $NFLX vs. $BABA vs. $EXPE Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=PCLN|NFLX|BABA|EXPE|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  13. Mix Performers in Focus- $CNX $SXC $EXPE http://www.streetwisereport.com/mix-performers-in-focus-consol-energy-inc-nysecnx-suncoke-energy-inc-nysesxc-expedia-inc-nasdaqexpe/112990/

  14. $NFLX vs. $AMZN vs. $PCLN vs. $EXPE Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=NFLX|AMZN|PCLN|EXPE|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  15. $NFLX vs. $BABA vs. $AMZN vs. $EXPE Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=NFLX|BABA|AMZN|EXPE|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  16. $EXPE headed to 100

  17. $EXPE looks attractive (rated 7.0 as price is down to 92.30). Price vs ratings chart: https://www.v2ratings.com/ratings/t/expe

  18. Wallick Investments holds an allocation of 1.6% in $EXPE in his Core Growth Investment Portfolio

  19. May 8th Options Now Available For Expedia ($EXPE) https://www.stockoptionschannel.com/articles/?a=EXPE03262015optn.htm&b=201503

  20. First Week of May 15th Options Trading For Expedia ($EXPE) https://www.stockoptionschannel.com/articles/?a=EXPE03262015optn.htm&b=201503

  21. Buyers IMO there is a TON of free money on the table at these levels with $SWKS, $N, $NVGN, $ARNA, $EXPE, $BOX, $ICPT !!!!

  22. $PCLN vs. $EXPE vs. $NFLX vs. $JD Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=PCLN|EXPE|NFLX|JD|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  23. Mix Performers in Focus- $EXPE $SNY $FUL http://www.streetwisereport.com/mix-performers-in-focus-expedia-inc-nasdaqexpe-sanofi-nysesny-hb-fuller-co-nyseful/112827/

  24. Insider Transaction: $EXPE Automatic Sale at $95.07 per share of 50000 shares by Officer Khosrowshahi Dara on 2015-03-20.

  25. $PCLN vs. $EXPE vs. $GRPN Compared Across 9 Critical Measures Full Chart: http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=PCLN|EXPE|GRPN&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)